FDA Holds Public Hearings on Nanotechnology

The US Food and Drug Administration (FDA) has decided to take on the daunting task of figuring out how the size of a material (versus its chemical composition) affects its toxicity.

In keeping with the theme of pithy little size innuendos like â''size mattersâ'', this is a big nut to crack. A lot of work, research, development of new tools, creating of new measurement standards, and lots of money and time will be required to sort it out.

But instead of â''letâ''s roll up our sleeves and get to workâ'' we get â''letâ''s have a public meeting.â''

There must be some real or imagined benefit to engaging in this kind of public theater, but I imagine whatever it is it will not likely bring us any closer to determining how the size of particles imparts its level of toxicity.

The assumption behind these types of meetings is to foster an environment of openness and transparency with the general public.

But I canâ''t help but think that TNTLog has it about right when it laments about public acceptance of technologies whether â''any kind of education, or even twenty years in a Soviet Gulag would change such entrenched views?â''


Tech Talk

IEEE Spectrum’s general technology blog, featuring news, analysis, and opinions about engineering, consumer electronics, and technology and society, from the editorial staff and freelance contributors.

Newsletter Sign Up

Sign up for the Tech Alert newsletter and receive ground-breaking technology and science news from IEEE Spectrum every Thursday.